🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 4 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/05/2002 30,06 30,90 27,60 27,66 -9,43% 10,98% 50.633
28/05/2002 35,52 35,52 27,06 30,54 -13,73% 23,82% 42.133
24/05/2002 35,76 35,76 33,60 35,40 -1,34% 6,04% 16.183
23/05/2002 36,60 36,90 33,00 35,88 +0,34% 10,66% 41.533
22/05/2002 37,02 38,40 35,52 35,76 -3,56% 7,78% 12.950
21/05/2002 39,30 39,30 37,02 37,08 -6,08% 5,80% 21.033
20/05/2002 39,84 40,20 38,46 39,48 +0,30% 4,37% 9.567
17/05/2002 38,76 39,48 38,16 39,36 +2,66% 3,41% 21.867
16/05/2002 40,02 40,02 37,92 38,34 -3,91% 5,25% 26.650
15/05/2002 39,00 40,02 38,16 39,90 +1,84% 4,77% 44.883
14/05/2002 37,68 39,24 36,90 39,18 +9,02% 6,21% 60.833
13/05/2002 35,70 37,50 35,16 35,94 +2,22% 6,55% 35.267
10/05/2002 33,72 35,88 32,46 35,16 +0,69% 10,14% 78.467
09/05/2002 36,90 37,80 34,32 34,92 -6,73% 9,43% 42.133
08/05/2002 40,80 40,80 36,66 37,44 -5,45% 10,15% 38.500
07/05/2002 42,42 43,50 38,28 39,60 -8,46% 12,31% 35.783
06/05/2002 45,00 45,48 42,06 43,26 -3,22% 7,60% 16.217
03/05/2002 44,40 45,00 42,00 44,70 +0,27% 6,76% 20.017
02/05/2002 45,48 46,08 42,30 44,58 -1,46% 8,31% 15.833
01/05/2002 44,16 45,54 42,60 45,24 +4,72% 6,66% 89.883
30/04/2002 39,90 44,10 39,00 43,20 +6,04% 12,78% 38.517
29/04/2002 42,36 43,86 40,20 40,74 -3,69% 8,64% 21.833
26/04/2002 44,10 44,52 42,18 42,30 -4,47% 5,31% 15.333
25/04/2002 43,20 44,34 42,18 44,28 +2,50% 5,00% 17.117
24/04/2002 42,90 43,92 42,72 43,20 +0,70% 2,80% 27.367
23/04/2002 43,56 44,34 42,66 42,90 -0,56% 3,86% 23.167
22/04/2002 44,04 44,40 42,06 43,14 -2,44% 5,31% 20.550
19/04/2002 43,32 44,34 43,32 44,22 +0,41% 2,35% 12.417
18/04/2002 45,90 46,26 43,32 44,04 -4,30% 6,41% 34.967
17/04/2002 47,10 47,64 45,90 46,02 -2,91% 3,69% 20.900